Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FLUOROURACIL Cause Thrombophlebitis superficial? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Thrombophlebitis superficial have been filed in association with FLUOROURACIL (FLUOROURACIL). This represents 0.0% of all adverse event reports for FLUOROURACIL.

7
Reports of Thrombophlebitis superficial with FLUOROURACIL
0.0%
of all FLUOROURACIL reports
0
Deaths
3
Hospitalizations

How Dangerous Is Thrombophlebitis superficial From FLUOROURACIL?

Of the 7 reports, 3 (42.9%) required hospitalization.

Is Thrombophlebitis superficial Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FLUOROURACIL. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does FLUOROURACIL Cause?

Diarrhoea (5,373) Neutropenia (4,400) Nausea (3,757) Vomiting (2,836) Off label use (2,788) Neuropathy peripheral (2,605) Thrombocytopenia (2,426) Fatigue (2,421) Disease progression (2,377) Febrile neutropenia (2,230)

What Other Drugs Cause Thrombophlebitis superficial?

DROSPIRENONE\ETHINYL ESTRADIOL (160) LENALIDOMIDE (121) ETHINYL ESTRADIOL\ETONOGESTREL (93) RIVAROXABAN (82) YAZ (78) YASMIN (65) TESTOSTERONE (62) HUMAN IMMUNOGLOBULIN G (43) ADALIMUMAB (40) CAPECITABINE (29)

Which FLUOROURACIL Alternatives Have Lower Thrombophlebitis superficial Risk?

FLUOROURACIL vs FLUOROURACIL\IRINOTECAN\LEUCOVORIN FLUOROURACIL vs FLUOROURACIL\IRINOTECAN\LEUCOVORIN\OXALIPLATIN FLUOROURACIL vs FLUOROURACIL\LEUCOVORIN\OXALIPLATIN FLUOROURACIL vs FLUOXETINE FLUOROURACIL vs FLUOXETINE\FLUOXETINE

Related Pages

FLUOROURACIL Full Profile All Thrombophlebitis superficial Reports All Drugs Causing Thrombophlebitis superficial FLUOROURACIL Demographics